These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3529516)

  • 1. Evaluation of a rapid ultrafiltration technique for determination of quinidine protein binding and comparison with equilibrium dialysis.
    Ha HR; Vozeh S; Follath F
    Ther Drug Monit; 1986; 8(3):331-5. PubMed ID: 3529516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of assay procedures used to measure total and unbound concentrations of quinidine.
    Wooding-Scott RA; Darling IM; Slaughter RL
    DICP; 1989 Dec; 23(12):999-1004. PubMed ID: 2690475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
    Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
    Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinidine assays: enzyme immunoassay versus high performance liquid chromatography.
    Lehmann CR; Boran KJ; Pierson WP; Melikian AP; Wright GJ
    Ther Drug Monit; 1986; 8(3):336-9. PubMed ID: 3529517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography and fluorescence spectroscopy compared with a homogeneous enzyme immunoassay technique for determining quinidine in serum.
    Drayer DE; Lorenzo B; Reidenberg MM
    Clin Chem; 1981 Feb; 27(2):308-10. PubMed ID: 7006859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
    Raghow G; Meyer MC; Straughn AB
    Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of free thyroid hormones in animal serum/plasma using ultrafiltration in combination with ultra-fast liquid chromatography-tandem mass spectrometry.
    Tanoue R; Kume I; Yamamoto Y; Takaguchi K; Nomiyama K; Tanabe S; Kunisue T
    J Chromatogr A; 2018 Mar; 1539():30-40. PubMed ID: 29395158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring unbound versus total vancomycin concentrations in serum and plasma: methodological issues and relevance.
    Stove V; Coene L; Carlier M; De Waele JJ; Fiers T; Verstraete AG
    Ther Drug Monit; 2015 Apr; 37(2):180-7. PubMed ID: 25072945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the binding of disopyramide to serum proteins.
    Shaw LM; Altman R; Thompson BC; Fields L
    Clin Chem; 1985 Apr; 31(4):616-9. PubMed ID: 3884182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.
    Drayer DE; Restivo K; Reidenberg MM
    J Lab Clin Med; 1977 Nov; 90(5):816-22. PubMed ID: 908870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the apparent protein binding of quinidine.
    Guentert TW; Oie S
    J Pharm Sci; 1982 Mar; 71(3):325-8. PubMed ID: 7069591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery.
    Garfinkel D; Mamelok RD; Blaschke TF
    Ann Intern Med; 1987 Jul; 107(1):48-50. PubMed ID: 3109296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of lidocaine free concentration.
    Beach CL; Ludden TM; Clementi WA; Allerheiligen SR
    Ther Drug Monit; 1986; 8(3):326-30. PubMed ID: 3529515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
    Wang C; Wang Q; Yuan Z; Liu W; Gu J; Zhang L
    Drug Dev Ind Pharm; 2010 Mar; 36(3):307-14. PubMed ID: 19670965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-pressure liquid chromatography method for serum quinidine and (3S)-3-hydroxyquinidine.
    Weidner N; Ladenson JH; Larson L; Kessler G; McDonald JM
    Clin Chim Acta; 1979 Jan; 91(1):7-13. PubMed ID: 761394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased quinidine plasma protein binding during hemodialysis.
    Kessler KM; Perez GO
    Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of a microcomputer for enzyme immunoassay (Emit) determination of serum quinidine concentrations.
    Sealfon MS; Hallberg N
    Am J Med Technol; 1983 Sep; 49(9):669-70. PubMed ID: 6372484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.